In vitro diagnostics for the medical dermatologist. Part II: Hypercoagulability tests
The skin often provides initial clues of hypercoagulability with features such as livedo reticularis, livedo racemosa, retiform purpura, necrosis, and ulcerations. Because these cutaneous manifestations are nonspecific, laboratory testing is often needed to evaluate for underlying causes of hypercoa...
Gespeichert in:
Veröffentlicht in: | Journal of the American Academy of Dermatology 2021-08, Vol.85 (2), p.301-310 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 310 |
---|---|
container_issue | 2 |
container_start_page | 301 |
container_title | Journal of the American Academy of Dermatology |
container_volume | 85 |
creator | Nusbaum, Kelsey B. Korman, Abraham M. Tyler, Kelly H. Kaffenberger, Jessica A. Trinidad, John C. Dean, Steven Cataland, Spero Kaffenberger, Benjamin H. |
description | The skin often provides initial clues of hypercoagulability with features such as livedo reticularis, livedo racemosa, retiform purpura, necrosis, and ulcerations. Because these cutaneous manifestations are nonspecific, laboratory testing is often needed to evaluate for underlying causes of hypercoagulability. Importantly, these disorders are reported to be the most common mimicker, resulting in an erroneous diagnosis of pyoderma gangrenosum. Understanding inherent properties of, and indications for, available tests is necessary for appropriate ordering and interpretation of results. Additionally, ordering of these tests in an indiscriminate manner may lead to inaccurate results, complicating the interpretation and approach to management. This second article in this continuing medical education series summarizes information on methodology, test characteristics, and limitations of several in vitro laboratory tests used for the work up of hypercoagulability and vasculopathic disease as it pertains to dermatologic disease. |
doi_str_mv | 10.1016/j.jaad.2021.03.108 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2513241152</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0190962221006812</els_id><sourcerecordid>2513241152</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-31b18ca400544ca8e79fe63a8c8f01e4d462b4165a8bc05b230b1cce7b0bb2353</originalsourceid><addsrcrecordid>eNp9kEtLAzEUhYMoWh9_wIVk6WbGm2QeGXEj4qMg6ELXIcncqSnTpiap0H9vStWlq8s9nHMu9yPknEHJgDVX83KudV9y4KwEkTW5RyYMurZoWtnukwmwDoqu4fyIHMc4B4CuEu0hORJC1rzj3YS8T5f0y6Xgae_0bOljcjbSwQeaPpAusHdWj7THsNDJj37mYirpqw6JTqfX9GmzwmC9nq1Hbdzo0oYmjCmekoNBjxHPfuYJeX-4f7t7Kp5fHqd3t8-FFXWTCsEMk1ZXAHVVWS2x7QZshJZWDsCw6quGm4o1tZbGQm24AMOsxdaAyUstTsjlrncV_Oc6X1YLFy2Oo16iX0fFayZ4xVjNs5XvrDb4GAMOahXcQoeNYqC2ONVcbXGqLU4FImsyhy5--tcms_iL_PLLhpudAfOXXw6Ditbh0mZuAW1SvXf_9X8DYMiGSA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2513241152</pqid></control><display><type>article</type><title>In vitro diagnostics for the medical dermatologist. Part II: Hypercoagulability tests</title><source>Access via ScienceDirect (Elsevier)</source><creator>Nusbaum, Kelsey B. ; Korman, Abraham M. ; Tyler, Kelly H. ; Kaffenberger, Jessica A. ; Trinidad, John C. ; Dean, Steven ; Cataland, Spero ; Kaffenberger, Benjamin H.</creator><creatorcontrib>Nusbaum, Kelsey B. ; Korman, Abraham M. ; Tyler, Kelly H. ; Kaffenberger, Jessica A. ; Trinidad, John C. ; Dean, Steven ; Cataland, Spero ; Kaffenberger, Benjamin H.</creatorcontrib><description>The skin often provides initial clues of hypercoagulability with features such as livedo reticularis, livedo racemosa, retiform purpura, necrosis, and ulcerations. Because these cutaneous manifestations are nonspecific, laboratory testing is often needed to evaluate for underlying causes of hypercoagulability. Importantly, these disorders are reported to be the most common mimicker, resulting in an erroneous diagnosis of pyoderma gangrenosum. Understanding inherent properties of, and indications for, available tests is necessary for appropriate ordering and interpretation of results. Additionally, ordering of these tests in an indiscriminate manner may lead to inaccurate results, complicating the interpretation and approach to management. This second article in this continuing medical education series summarizes information on methodology, test characteristics, and limitations of several in vitro laboratory tests used for the work up of hypercoagulability and vasculopathic disease as it pertains to dermatologic disease.</description><identifier>ISSN: 0190-9622</identifier><identifier>EISSN: 1097-6787</identifier><identifier>DOI: 10.1016/j.jaad.2021.03.108</identifier><identifier>PMID: 33852929</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>antiphospholipid antibodies ; cryofibrinogenemia ; cryoglobulinemia ; D-dimer ; diagnostic testing ; factor deficiency ; genetic thrombophilia ; hereditary thrombophilia ; hypercoagulability ; medical dermatology ; monoclonal gammopathy ; multiple myeloma ; pyoderma gangrenosum ; retiform purpura ; thrombogenic vasculopathy ; thrombotic vasculopathy ; ulcer</subject><ispartof>Journal of the American Academy of Dermatology, 2021-08, Vol.85 (2), p.301-310</ispartof><rights>2021 American Academy of Dermatology, Inc.</rights><rights>Copyright © 2021 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-31b18ca400544ca8e79fe63a8c8f01e4d462b4165a8bc05b230b1cce7b0bb2353</citedby><cites>FETCH-LOGICAL-c356t-31b18ca400544ca8e79fe63a8c8f01e4d462b4165a8bc05b230b1cce7b0bb2353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaad.2021.03.108$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33852929$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nusbaum, Kelsey B.</creatorcontrib><creatorcontrib>Korman, Abraham M.</creatorcontrib><creatorcontrib>Tyler, Kelly H.</creatorcontrib><creatorcontrib>Kaffenberger, Jessica A.</creatorcontrib><creatorcontrib>Trinidad, John C.</creatorcontrib><creatorcontrib>Dean, Steven</creatorcontrib><creatorcontrib>Cataland, Spero</creatorcontrib><creatorcontrib>Kaffenberger, Benjamin H.</creatorcontrib><title>In vitro diagnostics for the medical dermatologist. Part II: Hypercoagulability tests</title><title>Journal of the American Academy of Dermatology</title><addtitle>J Am Acad Dermatol</addtitle><description>The skin often provides initial clues of hypercoagulability with features such as livedo reticularis, livedo racemosa, retiform purpura, necrosis, and ulcerations. Because these cutaneous manifestations are nonspecific, laboratory testing is often needed to evaluate for underlying causes of hypercoagulability. Importantly, these disorders are reported to be the most common mimicker, resulting in an erroneous diagnosis of pyoderma gangrenosum. Understanding inherent properties of, and indications for, available tests is necessary for appropriate ordering and interpretation of results. Additionally, ordering of these tests in an indiscriminate manner may lead to inaccurate results, complicating the interpretation and approach to management. This second article in this continuing medical education series summarizes information on methodology, test characteristics, and limitations of several in vitro laboratory tests used for the work up of hypercoagulability and vasculopathic disease as it pertains to dermatologic disease.</description><subject>antiphospholipid antibodies</subject><subject>cryofibrinogenemia</subject><subject>cryoglobulinemia</subject><subject>D-dimer</subject><subject>diagnostic testing</subject><subject>factor deficiency</subject><subject>genetic thrombophilia</subject><subject>hereditary thrombophilia</subject><subject>hypercoagulability</subject><subject>medical dermatology</subject><subject>monoclonal gammopathy</subject><subject>multiple myeloma</subject><subject>pyoderma gangrenosum</subject><subject>retiform purpura</subject><subject>thrombogenic vasculopathy</subject><subject>thrombotic vasculopathy</subject><subject>ulcer</subject><issn>0190-9622</issn><issn>1097-6787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kEtLAzEUhYMoWh9_wIVk6WbGm2QeGXEj4qMg6ELXIcncqSnTpiap0H9vStWlq8s9nHMu9yPknEHJgDVX83KudV9y4KwEkTW5RyYMurZoWtnukwmwDoqu4fyIHMc4B4CuEu0hORJC1rzj3YS8T5f0y6Xgae_0bOljcjbSwQeaPpAusHdWj7THsNDJj37mYirpqw6JTqfX9GmzwmC9nq1Hbdzo0oYmjCmekoNBjxHPfuYJeX-4f7t7Kp5fHqd3t8-FFXWTCsEMk1ZXAHVVWS2x7QZshJZWDsCw6quGm4o1tZbGQm24AMOsxdaAyUstTsjlrncV_Oc6X1YLFy2Oo16iX0fFayZ4xVjNs5XvrDb4GAMOahXcQoeNYqC2ONVcbXGqLU4FImsyhy5--tcms_iL_PLLhpudAfOXXw6Ditbh0mZuAW1SvXf_9X8DYMiGSA</recordid><startdate>20210801</startdate><enddate>20210801</enddate><creator>Nusbaum, Kelsey B.</creator><creator>Korman, Abraham M.</creator><creator>Tyler, Kelly H.</creator><creator>Kaffenberger, Jessica A.</creator><creator>Trinidad, John C.</creator><creator>Dean, Steven</creator><creator>Cataland, Spero</creator><creator>Kaffenberger, Benjamin H.</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20210801</creationdate><title>In vitro diagnostics for the medical dermatologist. Part II: Hypercoagulability tests</title><author>Nusbaum, Kelsey B. ; Korman, Abraham M. ; Tyler, Kelly H. ; Kaffenberger, Jessica A. ; Trinidad, John C. ; Dean, Steven ; Cataland, Spero ; Kaffenberger, Benjamin H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-31b18ca400544ca8e79fe63a8c8f01e4d462b4165a8bc05b230b1cce7b0bb2353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>antiphospholipid antibodies</topic><topic>cryofibrinogenemia</topic><topic>cryoglobulinemia</topic><topic>D-dimer</topic><topic>diagnostic testing</topic><topic>factor deficiency</topic><topic>genetic thrombophilia</topic><topic>hereditary thrombophilia</topic><topic>hypercoagulability</topic><topic>medical dermatology</topic><topic>monoclonal gammopathy</topic><topic>multiple myeloma</topic><topic>pyoderma gangrenosum</topic><topic>retiform purpura</topic><topic>thrombogenic vasculopathy</topic><topic>thrombotic vasculopathy</topic><topic>ulcer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nusbaum, Kelsey B.</creatorcontrib><creatorcontrib>Korman, Abraham M.</creatorcontrib><creatorcontrib>Tyler, Kelly H.</creatorcontrib><creatorcontrib>Kaffenberger, Jessica A.</creatorcontrib><creatorcontrib>Trinidad, John C.</creatorcontrib><creatorcontrib>Dean, Steven</creatorcontrib><creatorcontrib>Cataland, Spero</creatorcontrib><creatorcontrib>Kaffenberger, Benjamin H.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Academy of Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nusbaum, Kelsey B.</au><au>Korman, Abraham M.</au><au>Tyler, Kelly H.</au><au>Kaffenberger, Jessica A.</au><au>Trinidad, John C.</au><au>Dean, Steven</au><au>Cataland, Spero</au><au>Kaffenberger, Benjamin H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro diagnostics for the medical dermatologist. Part II: Hypercoagulability tests</atitle><jtitle>Journal of the American Academy of Dermatology</jtitle><addtitle>J Am Acad Dermatol</addtitle><date>2021-08-01</date><risdate>2021</risdate><volume>85</volume><issue>2</issue><spage>301</spage><epage>310</epage><pages>301-310</pages><issn>0190-9622</issn><eissn>1097-6787</eissn><abstract>The skin often provides initial clues of hypercoagulability with features such as livedo reticularis, livedo racemosa, retiform purpura, necrosis, and ulcerations. Because these cutaneous manifestations are nonspecific, laboratory testing is often needed to evaluate for underlying causes of hypercoagulability. Importantly, these disorders are reported to be the most common mimicker, resulting in an erroneous diagnosis of pyoderma gangrenosum. Understanding inherent properties of, and indications for, available tests is necessary for appropriate ordering and interpretation of results. Additionally, ordering of these tests in an indiscriminate manner may lead to inaccurate results, complicating the interpretation and approach to management. This second article in this continuing medical education series summarizes information on methodology, test characteristics, and limitations of several in vitro laboratory tests used for the work up of hypercoagulability and vasculopathic disease as it pertains to dermatologic disease.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>33852929</pmid><doi>10.1016/j.jaad.2021.03.108</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0190-9622 |
ispartof | Journal of the American Academy of Dermatology, 2021-08, Vol.85 (2), p.301-310 |
issn | 0190-9622 1097-6787 |
language | eng |
recordid | cdi_proquest_miscellaneous_2513241152 |
source | Access via ScienceDirect (Elsevier) |
subjects | antiphospholipid antibodies cryofibrinogenemia cryoglobulinemia D-dimer diagnostic testing factor deficiency genetic thrombophilia hereditary thrombophilia hypercoagulability medical dermatology monoclonal gammopathy multiple myeloma pyoderma gangrenosum retiform purpura thrombogenic vasculopathy thrombotic vasculopathy ulcer |
title | In vitro diagnostics for the medical dermatologist. Part II: Hypercoagulability tests |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T20%3A43%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20diagnostics%20for%20the%20medical%20dermatologist.%20Part%20II:%20Hypercoagulability%20tests&rft.jtitle=Journal%20of%20the%20American%20Academy%20of%20Dermatology&rft.au=Nusbaum,%20Kelsey%20B.&rft.date=2021-08-01&rft.volume=85&rft.issue=2&rft.spage=301&rft.epage=310&rft.pages=301-310&rft.issn=0190-9622&rft.eissn=1097-6787&rft_id=info:doi/10.1016/j.jaad.2021.03.108&rft_dat=%3Cproquest_cross%3E2513241152%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2513241152&rft_id=info:pmid/33852929&rft_els_id=S0190962221006812&rfr_iscdi=true |